Talphera, Inc.
TLPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427925
No open-market purchases or sales by Talphera, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $24.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Talphera, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 56 | 37 | −19 |
| SharesConverted for a 1-for-20 split | 912.5K | 1.46M | +543.2K (+59.5%) |
| Value | $3.81M | $3.29M | −$523.6K (−13.7%) |
New holders (9)
Institutions that held Talphera, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 367,102 | $829.7K | 0.02% |
| Susquehanna International Group, LLP | 63,554 | $143.6K | 0.00% |
| Citigroup Inc | 3,592 | $8.12K | 0.00% |
| Cedar Wealth Management, LLC | 250 | $565 | 0.00% |
| Advisory Services Network, LLC | 187 | $423 | 0.00% |
| Silicon Valley Capital Partners | 137 | $310 | 0.00% |
| Credit Suisse AG | 30 | $68 | 0.00% |
| JPMorgan Chase & Co | 208 | $0 | 0.00% |
| Royal Bank of Canada | 13 | $0 | 0.00% |
Sold out (28)
Institutions that held Talphera, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.